Johnson & Johnson
-
Global healthcare leaders advance sector decarbonisation ahead of COP28
China and India are key markets for pharmaceutical manufacturing, estimated to account for up to 50 per cent of materials…
Read More » -
Johnson & Johnson appoints Anuj Virmani as MD of MedTech India division
Virmani who comes with 28 years of industry experience Johnson & Johnson has appointed Anuj Virmani as the Managing Director…
Read More » -
Johnson & Johnson appoints senior leaders to Executive Committee
Alex Gorsky will serve as Executive Chairman of Johnson & Johnson and transition the Chief Executive Officer role to Joaquin…
Read More » -
Janssen presents results of biologic therapies in patients with Crohn’s Disease
The SEAVUE study examined a total of 386 patients with moderately to severely active CD patients The Janssen Pharmaceutical Companies…
Read More » -
J&J seeks permission for phase-3 trial of COVID vaccine in India
The company also seeks regulator’s permission to import licence Multinational pharma giant Johnson & Johnson has applied to India’s drug…
Read More » -
WHO approves Johnson & Johnson’s COVID-19 vaccine for emergency listing
This is the third COVID-19 vaccine after the two-shot regimens of Pfizer/BioNTech and AstraZeneca to receive backing from the WHO…
Read More » -
Johnson & Johnson’s COVID-19 vaccine authorised in US
J&J expects to produce at least a billion doses of its vaccine in 2021 Johnson & Johnson’s COVID-19 vaccine was…
Read More » -
J&J starts two-dose trial of COVID-19 vaccine in the UK
The UK arm of the study is aiming to recruit 6,000 participants among a total of 30,000 people globally Johnson…
Read More » -
J&J plans to test its COVID-19 vaccine in ages 12-18 soon
Depending on safety and other factors, the company plans to test in even younger children afterwards Johnson & Johnson plans…
Read More »